# Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions

> **NCT00491894** · PHASE3 · COMPLETED · sponsor: **Shionogi** · enrollment: 137 (actual)

## Conditions studied

- Cerebral Palsy
- Neurological Conditions
- Mental Retardation
- Sialorrhea

## Interventions

- **DRUG:** Oral Glycopyrrolate Liquid

## Key facts

- **NCT ID:** NCT00491894
- **Lead sponsor:** Shionogi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-05
- **Final completion:** 2008-06
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2012-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00491894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00491894, "Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00491894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*